Prostate carcinoma is one of the most commonly diagnosed solid tumours in males worldwide. Availability of diagnostic tests is constantly increasing in clinical practice, allowing early diagnosis and better chances for complete and permanent recovery. In the case of locally advanced prostate carcinoma, radical surgery or radiotherapy are considered as the most effective therapeutic approaches, whereas in metastatic prostate carcinoma, hormone therapy or androgen deprivation therapy (ADT) are the primary therapeutic options. The biggest challenge for doctors and patients remains the treatment of hormone-resistant carcinoma (which very often is also metastatic). Bozena Sikora-Kupis at KCR navigates the concerns of today’s medicine regarding effective therapies for this type of disease.
Therapeutics 2 – Prostate